• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVaccine

Vaccine

Page 11 of 13
You can now sign up to participate in COVID-19 vaccine clinical trials
HealthYou can now sign up to participate in COVID-19 vaccine clinical trials
By Jonathan VanianJuly 8, 2020
Brainstorm-Health-2020-Gerberding-Neidorff
ConferencesHealth care executives fear public distrust of COVID-19 vaccine will lead to continued spread of disease
By Nicole GoodkindJuly 8, 2020
Gary Rieschel
He invested in a top COVID-19 vaccine—and says development isn’t a U.S.-China race
By Veta ChanJuly 2, 2020
Dr. Fauci’s worst nightmare? We’re living it
HealthDr. Fauci’s worst nightmare? We’re living it
By John Lauerman, Riley Griffin and BloombergJune 10, 2020
British pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
HealthBritish pharma giant AstraZeneca get $1 billion from the U.S. to make coronavirus vaccine
By John Lauerman and BloombergMay 21, 2020
A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants.
NewslettersThe man who made Moderna
By David Meyer and Alan MurrayMay 19, 2020
‘Unacceptable:’ A new France-U.S. spat erupts over Sanofi’s coronavirus vaccine plans
Health‘Unacceptable:’ A new France-U.S. spat erupts over Sanofi’s coronavirus vaccine plans
By Phil Serafino and BloombergMay 14, 2020
The U.S. has a new plan to fast-track a COVID-19 vaccine: ‘Operation Warp Speed’
PoliticsThe U.S. has a new plan to fast-track a COVID-19 vaccine: ‘Operation Warp Speed’
By Jennifer Jacobs, Drew Armstrong and BloombergApril 30, 2020
In race to make a coronavirus vaccine, AstraZeneca joins forces with Oxford University
HealthIn race to make a coronavirus vaccine, AstraZeneca joins forces with Oxford University
By Marthe Fourcade, John Lauerman and BloombergApril 30, 2020
Bill Gates’ coronavirus vaccine could be manufacturing at scale in a year
HealthBill Gates’ coronavirus vaccine could be manufacturing at scale in a year
By Hailey Waller, Lucca de Paoli and BloombergApril 26, 2020
What we know about COVID-19
MagazineWhat we know about COVID-19
By Clifton LeafApril 20, 2020
J&J coronavirus vaccine
NewslettersJohnson & Johnson CEO on the race to make a coronavirus vaccine
By Katherine Dunn and Alan MurrayMarch 31, 2020
Measles
HealthMeasles Outbreaks Nearing Levels Not Seen Since 1992. Anti-Vax Propaganda Is Partly to Blame
By Brittany ShootMarch 8, 2019
Pfizer Acquires Wyeth For $68 Billion
HealthPfizer’s Best-Selling Drug Is Actually a Vaccine—and Its Price Keeps Increasing
By Brittany ShootFebruary 5, 2019
Malaria Summit Asks The Commonwealth For Help Eradicating The Disease
LeadershipBill Gates Says These Global Health Investments Were the Best He’s Ever Made. Here’s Why
By Brittany ShootJanuary 17, 2019
1...
  • 9
  • 10
  • 11
  • 12
  • 13
13
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.